Published in Breast Cancer Res Treat on May 13, 2015
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial. Breast Cancer Res (2015) 0.89
Use of Insulin and Mortality from Breast Cancer among Taiwanese Women with Diabetes. J Diabetes Res (2015) 0.83
Obesity and male breast cancer: provocative parallels? BMC Med (2015) 0.80
Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study. Cancer Causes Control (2016) 0.76
Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics. BMC Cancer (2015) 0.76
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer. PLoS One (2017) 0.75
Obesity causes lymphatic vascular injury: time for clinical translation. J Physiol (2016) 0.75
A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer. PLoS One (2016) 0.75
Genetic Control of Flower Development by Homeotic Genes in Antirrhinum majus. Science (1990) 7.30
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med (2000) 6.98
Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet (2000) 6.95
Complementary floral homeotic phenotypes result from opposite orientations of a transposon at the plena locus of Antirrhinum. Cell (1993) 4.47
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology (1984) 4.09
GLOBOSA: a homeotic gene which interacts with DEFICIENS in the control of Antirrhinum floral organogenesis. EMBO J (1992) 3.61
Bracteomania, an inflorescence anomaly, is caused by the loss of function of the MADS-box gene squamosa in Antirrhinum majus. EMBO J (1992) 3.60
Genetic engineering of parthenocarpic plants. Nat Biotechnol (1997) 3.31
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Open reduction and internal fixation of proximal humeral fractures with use of the locking proximal humerus plate. Results of a prospective, multicenter, observational study. J Bone Joint Surg Am (2009) 3.15
The 17-kb Tam1 element of Antirrhinum majus induces a 3-bp duplication upon integration into the chalcone synthase gene. EMBO J (1984) 3.07
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord (2001) 2.94
Nucleotide sequence of the transposable DNA-element IS2. Nucleic Acids Res (1979) 2.89
Ternary complex formation between the MADS-box proteins SQUAMOSA, DEFICIENS and GLOBOSA is involved in the control of floral architecture in Antirrhinum majus. EMBO J (1999) 2.88
Triple-negative breast cancer--current status and future directions. Ann Oncol (2009) 2.78
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene (2000) 2.71
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.63
Molecular analysis of instability in flower pigmentation of Antirrhinum majus, following isolation of the pallida locus by transposon tagging. EMBO J (1985) 2.48
Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology (1991) 2.42
Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry (1974) 2.42
Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol (1994) 2.27
Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol (2003) 2.22
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol (2000) 1.99
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat (1993) 1.97
Multiple interactions amongst floral homeotic MADS box proteins. EMBO J (1996) 1.96
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Mussel Poisoning. Cal West Med (1935) 1.94
Genetic studies of the lac repressor. IX. Generation of altered proteins by the suppression of nonsence mutations. J Mol Biol (1979) 1.88
PLENA and FARINELLI: redundancy and regulatory interactions between two Antirrhinum MADS-box factors controlling flower development. EMBO J (1999) 1.87
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost (1997) 1.78
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
The transposable element Tam1 from Antirrhinum majus shows structural homology to the maize transposon En/Spm and has no sequence specificity of insertion. Mol Gen Genet (1991) 1.77
Spatial and temporal regulation of gap junction connexin43 in vascular endothelial cells exposed to controlled disturbed flows in vitro. Proc Natl Acad Sci U S A (1999) 1.75
Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A (2003) 1.74
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J Natl Cancer Inst (2001) 1.71
The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study. Diabetologia (2006) 1.69
IS1-mediated DNA rearrangements. Cold Spring Harb Symp Quant Biol (1981) 1.68
Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord (2003) 1.62
Proximal humeral fractures: how stiff should an implant be? A comparative mechanical study with new implants in human specimens. Arch Orthop Trauma Surg (2003) 1.61
Management of venous port systems in oncology: a review of current evidence. Ann Oncol (2007) 1.52
Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J Clin Endocrinol Metab (2014) 1.49
Integration of IS3 into IS2 generates a short sequence duplication. Mol Gen Genet (1979) 1.49
Segmental portal hypertension. Ann Surg (1986) 1.47
Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion. Plast Reconstr Surg (1999) 1.46
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord (2004) 1.43
Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes (2000) 1.43
Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol (1995) 1.40
[Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics]. Fortschr Neurol Psychiatr (2008) 1.39
[Paraffin embedding for hemispherial slides within 10 days]. Acta Neuropathol (1967) 1.39
Tl(2)CO(3) at 3.56 GPa. Acta Crystallogr C (2008) 1.38
Evaluation of routine upper digestive tract endoscopy before laparoscopic cholecystectomy. Br J Surg (1992) 1.38
A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet (1999) 1.37
Structural analysis of Tam3, a transposable element from Antirrhinum majus, reveals homologies to the Ac element from maize. Plant Mol Biol (1991) 1.36
Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes (1996) 1.33
Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control (2000) 1.31
Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol (2000) 1.29
[St. John's wort extract in the ambulatory therapy of depression. Attention and reaction ability are preserved]. Fortschr Med (1993) 1.28
Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol (2001) 1.28
Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol (2003) 1.25
uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial. Adv Clin Chem (2008) 1.25
Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007. Exp Clin Endocrinol Diabetes (2011) 1.25
Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat (2006) 1.21
Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients. Q J Nucl Med Mol Imaging (2010) 1.20
Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Clin Exp Immunol (1980) 1.20
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res (2001) 1.19
IS2-43 and IS2-44: new alleles of the insertion sequence IS2 which have promoter activity. Mol Gen Genet (1979) 1.18
Molecular characterization of two stamen-specific genes, tap1 and fil1, that are expressed in the wild type, but not in the deficiens mutant of Antirrhinum majus. Mol Gen Genet (1991) 1.17
Activation and activation-driven death of human gamma/delta T cells. Immunol Rev (1991) 1.16
Quality of life influenced by primary surgical treatment for stage I-III breast cancer-long-term follow-up of a matched-pair analysis. Ann Surg Oncol (2001) 1.15
Cloning of the potato virus Y genes encoding the capsid protein CP and the nuclear inclusion protein NIb. Arch Virol (1989) 1.14
Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol (1996) 1.14
NTGLO: a tobacco homologue of the GLOBOSA floral homeotic gene of Antirrhinum majus: cDNA sequence and expression pattern. Mol Gen Genet (1993) 1.14
Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol (2001) 1.14
Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat (2013) 1.14
Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study. Exp Clin Endocrinol Diabetes (2007) 1.13
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer (2013) 1.12
A new type of IS1-mediated deletion. Mol Gen Genet (1981) 1.11
Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod (2002) 1.11
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients. Ann Oncol (2012) 1.11
Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer (1996) 1.10
Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat (2000) 1.10
FasL:Fas ratio--a prognostic factor in breast carcinomas. Cancer Res (2000) 1.10
Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer. Br J Cancer (1997) 1.09
Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest (1997) 1.08
Transforming growth factor beta (TGF-beta) inhibits the differentiation of human adipocyte precursor cells in primary culture. Int J Obes Relat Metab Disord (1994) 1.08
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. Oncol Rep (2006) 1.08
Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr (1979) 1.07
A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat (1999) 1.07